Πέμπτη 13 Οκτωβρίου 2022

Outcomes in Patients With Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors

alexandrossfakianakis shared this article with you from Inoreader

ooi220045t1_1664995497.34322.png?Expires

This cohort study assesses survival outcomes and response rates among patients with recurrent or metastatic mucosal head and neck squamous cell carcinoma treated with checkpoint inhibitors with or without chemotherapy.
View on Web

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου